SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on upcoming Phase 2 maintenance data for its weight-loss candidate, VK2735. While the community remains divided over the CEO's conservative communication style and the lack of a clear partnership, sentiment is buoyed by hopes that the data will demonstrate best-in-class efficacy.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle shares are experiencing volatility ahead of a key Senate procedural vote on the Digital Asset Market Clarity Act. While some investors see the legislation as a major catalyst for long-term growth and potential short squeezes, others remain skeptical, citing concerns over high competition from bank-issued stablecoins and the potential for a pullback if the bill fails to advance.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending following a strong quarterly earnings report that featured record bookings and a significant backlog, alongside optimistic fiscal 2027 guidance and planned capacity expansions. While investor sentiment is largely bullish, some traders are debating the company's valuation relative to its high growth and monitoring the impact of recent secondary share offerings.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to heightened geopolitical tensions in the Middle East, particularly following attacks on Saudi Arabian oil infrastructure and ongoing volatility in the Strait of Hormuz. Traders are actively debating whether these supply disruptions justify the recent surge in prices or if technical overextension and potential diplomatic interventions suggest a forthcoming pullback.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the submission of a Biologics License Application (BLA) for its IgA nephropathy treatment, atacicept, seeking FDA accelerated approval. Traders are closely monitoring the company's strong institutional backing and high short interest, with many discussing its potential as a buyout candidate or a target for a significant short squeeze.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is experiencing downward pressure largely attributed to high oil prices, which investors fear will increase operating costs and dampen profitability. Despite these concerns, some retail traders express frustration with perceived market manipulation and short-selling activity, maintaining a bullish long-term outlook based on the company's revenue recovery and the potential for a rebound once fuel-related headwinds subside.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros shares are experiencing a sharp sell-off following second-quarter results, with investors reacting to concerns over slowing same-store sales growth, a premium valuation, and risks associated with its recent acquisition of former Salad and Go locations. While many traders see the decline as a buying opportunity given the company's strong revenue beat and expansion plans, others are pivoting to lower valuations or expressing skepticism regarding the sustainability of the company's growth in a challenging consumer environment.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is experiencing significant price volatility following a definitive agreement to acquire the Ukrainian drone manufacturer Ratel Robotics for up to $224 million. While some traders view the acquisition and the company's defense-sector connections as bullish catalysts, others are expressing concern over pending share lock-up expirations, potential dilution, and the firm's limited revenue history.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals shares are experiencing volatility and investor frustration as the community debates the impact of institutional price manipulation, algorithm-driven trading, and ongoing share price consolidation. Despite positive clinical pipeline developments, participants remain divided between those accumulating shares on dips and those expressing dismay over the lack of sustained momentum.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending as traders debate the stock's valuation and the company's aggressive growth strategy following a recent decline from its highs. While bulls point to strong unit expansion and revenue metrics as indicators of long-term potential, bears argue the current price-to-earnings multiple is unsustainable and vulnerable to consumer spending fatigue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$UUUU Energy Fuels ($UUUU) is becoming increasingly interesting from a technical perspective despite the sharp sell-off. After dropping roughly 15% in just one week, the stock appears heavily oversold and is now approaching a major support zone around $12. The 3M and 6M charts show that the $11–12 area previously served as the foundation for a powerful rebound toward $16. A similar bottoming process could develop again. The speed and magnitude of the latest decline also increase the probability of a technical rebound. A recovery above $13 would open the door toward $13.50–13.80. Above $14.50–15, the technical picture would improve significantly, potentially putting $16 back into focus. As long as the broader $11–12 support zone holds, the current setup offers an interesting risk/reward profile for a potential reversal. $UEC $CCJ $DNN

Andreas Pfeiffer

Andrew McGarry

LMAO

StockTwits For Android 

Energy Fuels Inc

Uranium Energy Corp

Cameco Corp.

Denison Mines Corp

) is becoming increasingly interesting from a technical perspective despite the sharp sell-off. After dropping roughly 15% in just one week, the stock appears heavily oversold and is now approaching a major support zone around $12. The 3M and 6M charts show that the $11–12 area previously served as the foundation for a powerful rebound toward $16. A similar bottoming process could develop again. The speed and magnitude of the latest decline also increase the probability of a technical rebound. A recovery above $13 would open the door toward $13.50–13.80. Above $14.50–15, the technical picture would improve significantly, potentially putting $16 back into focus. As long as the broader $11–12 support zone holds, the current setup offers an interesting risk/reward profile for a potential reversal. 

@AlphaCharge  
 
We&#39;ll likely be in the $11 range shortly here today. 
 
There is little support, most heavily shorted stock in the entire minerals sector at nearly 22%(!) of the float, and we&#39;re deep red for the *4th consecutive session* with no rebound whatsoever. 
 
Expecting to be oversold on the RSI by FOMC at 2PM tomorrow, which &quot;should&quot; mark the bottom, but who knows, if the Fed is hawkish and spooks the equity markets we might shoot down into mid-20s or lower on the RSI before hitting bottom by end of week.

StockTwits Web

  
 
We'll likely be in the $11 range shortly here today. 
 
There is little support, most heavily shorted stock in the entire minerals sector at nearly 22%(!) of the float, and we're deep red for the *4th consecutive session* with no rebound whatsoever. 
 
Expecting to be oversold on the RSI by FOMC at 2PM tomorrow, which "should" mark the bottom, but who knows, if the Fed is hawkish and spooks the equity markets we might shoot down into mid-20s or lower on the RSI before hitting bottom by end of week.